MX2020002545A - Composicion para suplementacion de calcio. - Google Patents

Composicion para suplementacion de calcio.

Info

Publication number
MX2020002545A
MX2020002545A MX2020002545A MX2020002545A MX2020002545A MX 2020002545 A MX2020002545 A MX 2020002545A MX 2020002545 A MX2020002545 A MX 2020002545A MX 2020002545 A MX2020002545 A MX 2020002545A MX 2020002545 A MX2020002545 A MX 2020002545A
Authority
MX
Mexico
Prior art keywords
composition
calcium supplementation
supplementation
calcium
formulation
Prior art date
Application number
MX2020002545A
Other languages
English (en)
Inventor
Fabio Neggiani
Laura Dini
Samuele Zanatta
Original Assignee
Abiogen Pharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma Spa filed Critical Abiogen Pharma Spa
Publication of MX2020002545A publication Critical patent/MX2020002545A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A23L27/37—Halogenated sugars
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A23L29/27—Xanthan not combined with other microbial gums
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/40—Packages formed by enclosing successive articles, or increments of material, in webs, e.g. folded or tubular webs, or by subdividing tubes filled with liquid, semi-liquid, or plastic materials
    • B65D75/44—Individual packages cut from webs or tubes
    • B65D75/48—Individual packages cut from webs or tubes containing liquids, semiliquids, or pastes, e.g. cushion-shaped packages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/042—Lactic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1578—Calcium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/50—Polysaccharides, gums
    • A23V2250/502—Gums
    • A23V2250/5086—Xanthan

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pediatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mechanical Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

La presente invención se relaciona con una formulación en forma de suspensión acuosa que comprende citrato de calcio; dicha formulación exhibe excelente estabilidad y cumplimiento y encuentra uso en la suplementación con calcio en sujetos que necesitan dicha suplementación.
MX2020002545A 2017-09-06 2018-09-06 Composicion para suplementacion de calcio. MX2020002545A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102017000099690A IT201700099690A1 (it) 2017-09-06 2017-09-06 Composizione per l’integrazione di calcio
PCT/EP2018/073979 WO2019048532A1 (en) 2017-09-06 2018-09-06 CALCIUM SUPPLEMENTATION COMPOSITION

Publications (1)

Publication Number Publication Date
MX2020002545A true MX2020002545A (es) 2020-10-01

Family

ID=60991327

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020002545A MX2020002545A (es) 2017-09-06 2018-09-06 Composicion para suplementacion de calcio.

Country Status (23)

Country Link
US (1) US11058138B2 (es)
EP (1) EP3678497B1 (es)
JP (1) JP7308186B2 (es)
CN (1) CN111511222B (es)
AU (1) AU2018327614B2 (es)
BR (1) BR112020004453B1 (es)
CY (1) CY1124633T1 (es)
DK (1) DK3678497T3 (es)
EA (1) EA202090654A1 (es)
ES (1) ES2894115T3 (es)
HR (1) HRP20211530T1 (es)
HU (1) HUE056883T2 (es)
IL (1) IL273032B (es)
IT (1) IT201700099690A1 (es)
LT (1) LT3678497T (es)
MX (1) MX2020002545A (es)
NZ (1) NZ762357A (es)
PL (1) PL3678497T3 (es)
PT (1) PT3678497T (es)
SA (1) SA520411478B1 (es)
SI (1) SI3678497T1 (es)
SM (1) SMT202100606T1 (es)
WO (1) WO2019048532A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117137943A (zh) * 2023-07-12 2023-12-01 江苏艾兰得营养品有限公司 一种混悬型液体钙的制备工艺及其稳定性评价方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851221A (en) * 1985-02-19 1989-07-25 Mission Pharmacal Company Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid
US5075499A (en) * 1988-11-21 1991-12-24 Board Of Regents, The University Of Texas System Calcium supplementation by dicalcium citrate-lactate
US5232709A (en) * 1990-08-06 1993-08-03 The Procter & Gamble Company Calcium and trace mineral supplements comprising estrogen
RU2153330C2 (ru) * 1993-09-09 2000-07-27 Гергели Герхард Шипучий гранулят и способ его получения
WO1996031130A2 (en) * 1995-04-07 1996-10-10 Abbott Laboratories Calcium supplements and calcium containing beverages comprising vitamin d
US5597595A (en) * 1995-04-07 1997-01-28 Abbott Laboratories Low pH beverage fortified with calcium and vitamin D
US5817351A (en) * 1995-04-07 1998-10-06 Abbott Laboratories Calcium fortified low pH beverage
KR20070005550A (ko) * 2003-11-17 2007-01-10 바이오마린 파머수티컬 인크. 대사 장애 치료를 위한 조성물 및 방법
CN1901817A (zh) * 2003-12-04 2007-01-24 普拉克生化公司 含有乳酸葡糖酸柠檬酸钙的淡口感钙强化饮料
US7267832B2 (en) * 2004-02-18 2007-09-11 Kraft Foods Holdings, Inc. Amorphous water-soluble calcium citrate salts and method of making and using same
WO2007035760A1 (en) * 2005-09-20 2007-03-29 Board Of Regents, The University Of Texas System Enhanced solubility of preformed calcium citrate by adding citric acid
US7968130B2 (en) * 2006-01-11 2011-06-28 Mission Pharmacal Co. Calcium-enriched food product
WO2007098092A2 (en) * 2006-02-21 2007-08-30 Nutrijoy, Inc. Food and beverage products with improved taste impressions
EP2198889A1 (en) * 2008-12-22 2010-06-23 Almirall, S.A. Liquid pharmaceutical compositions comprising a triptan compound and Xylitol
CN101904350B (zh) * 2010-07-23 2013-09-25 内蒙古伊利实业集团股份有限公司 一种强化钙含量的发酵乳饮料及其生产方法
US20120280055A1 (en) * 2011-04-20 2012-11-08 Sterling International Inc. Method and dispenser for controlled release of semiochemicals
EP2462922A1 (en) * 2010-12-10 2012-06-13 Bioprojet New form of administration of enkephalinase inhibitor
EA201590855A1 (ru) * 2012-11-15 2015-11-30 Фармасайкликс, Инк. Соединения пирролопиримидина как ингибиторы киназ
WO2020219615A1 (en) * 2019-04-23 2020-10-29 Tetra Discovery Partners, Inc. 3-hydroxy-2-phenyl-6-(pyrazol-4-ylmethyl)pyridine derivatives as pde4d inhibitors

Also Published As

Publication number Publication date
US20200375238A1 (en) 2020-12-03
CA3074893A1 (en) 2019-03-14
CN111511222B (zh) 2023-05-30
HUE056883T2 (hu) 2022-03-28
SA520411478B1 (ar) 2022-08-04
IL273032B (en) 2022-01-01
DK3678497T3 (da) 2021-09-20
SMT202100606T1 (it) 2021-11-12
ES2894115T3 (es) 2022-02-11
PL3678497T3 (pl) 2022-01-31
SI3678497T1 (sl) 2022-01-31
CN111511222A (zh) 2020-08-07
HRP20211530T1 (hr) 2021-12-24
IT201700099690A1 (it) 2019-03-06
BR112020004453B1 (pt) 2023-11-14
AU2018327614A1 (en) 2020-03-19
WO2019048532A1 (en) 2019-03-14
EP3678497A1 (en) 2020-07-15
JP7308186B2 (ja) 2023-07-13
BR112020004453A2 (pt) 2020-09-15
IL273032A (en) 2020-04-30
EP3678497B1 (en) 2021-07-21
CY1124633T1 (el) 2022-07-22
PT3678497T (pt) 2021-10-04
EA202090654A1 (ru) 2020-06-24
US11058138B2 (en) 2021-07-13
KR20200083971A (ko) 2020-07-09
AU2018327614B2 (en) 2024-05-16
NZ762357A (en) 2025-12-19
LT3678497T (lt) 2021-12-27
JP2020532569A (ja) 2020-11-12

Similar Documents

Publication Publication Date Title
MX2020005063A (es) Inhibidores de kras g12c.
MX2017015236A (es) Beneficios de la suplementacion con n-acetilcisteina y glicina para mejorar los niveles de glutation.
CL2016001547A1 (es) Composiciones para el cuidado oral
UY36759A (es) Derivado de glucagón y una composición que comprende un conjugado de acción prolongada del mismo
BR112018075140A2 (pt) composição na forma de uma solução aquosa injetável, e, formulação de dose única a um ph de 7 a 7,8
MX374348B (es) Formulacion adhesiva y metodos de plisado utilizando la misma.
AR098168A1 (es) Formulación estable de insulina glulisina
BR112018003184A2 (pt) absorvente feminino com braçadeiras de barreira
CL2019002729A1 (es) Formulaciones de ácido 1-amino-1-ciclopropanocarboxílico.
MX2018002416A (es) Derivados de 1,7-diaril-1,6-heptadien-3,5-diona, procedimiento para la preparación y uso de los mismos.
BR112017015159A2 (pt) preparação e uso de produtos plaquetários
CO2018007810A2 (es) Formulación líquida estable de gonadotropina
MX391152B (es) Formulaciones farmaceuticas que comprenden cangrelor de alta pureza y metodos para preparar y utilizar las mismas.
CL2019002733A1 (es) Formulaciones de clorhidrato del ácido 1-amino-1-ciclopropanocarboxílico.
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
MX2020004675A (es) Formulaciones de alcohol de seda.
MX380314B (es) Citotoxinas modificadas y su uso terapeutico.
DOP2020000104A (es) Métodos de uso y composiciones que contienen dulaglutida
MX2017004531A (es) Composiciones para usarse en extraccion de micotoxina.
MX388400B (es) Una composición de dos componentes, que comprende ácido acetilsalicílico.
MX2020002545A (es) Composicion para suplementacion de calcio.
UY37572A (es) Una composición farmacéutica que comprende un derivado de oxazina y su uso en el tratamiento o la prevención de la enfermedad de alzheimer
CL2020001705A1 (es) Composición acuosa que comprende ácido 2-(dimetil-1h-pirazol-1-il) succínico y amoníaco.
TR201819130T4 (tr) Sulu Formülasyonlar, Bunların Üretimi Ve Kullanımı
CL2019002283A1 (es) Composición líquida que contiene pradofloxacina.